UNSPSC 51451610: Lobendazole

This classification denotes an antihelminthic agent with the molecular formula C10H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CMF6Z78SWL, chemically known as 2-benzimidazolecarbamic acid, ethyl ester (8ci) but generally known as lobendazole, which bears US NIH Compound Identifier 22752. European Medicines Agency schedules Lobendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08542MIG.

UNSPSC 51451610 Lobendazole, a Commodity code, shows minimal alignment between its nominal scope and the recent state and local solicitations tagged under it. The code nominally identifies a specific antiparasitic pharmaceutical, yet recent opportunities posted under this code encompass naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products distributed through cooperative purchasing, and medical and first aid supplies for emergency response—none of which are lobendazole. State and local governments are not actively soliciting lobendazole itself through the opportunities presently tagged to this code.

The recent activity reflects a broader pattern in state and local pharmaceutical procurement: cooperative purchasing agreements and health agency demand for emergency response supplies, naloxone distribution programs, and generic pharmaceutical sourcing through established wholesaler networks. The Texas Health and Human Services Commission has issued an RFI to explore direct-to-manufacturer prescription programs; Seminole County, Florida is procuring naloxone and drug deactivation systems through an IFB (due July 26, 2023, though posted June 30, 2026); the City of Tampa is seeking medical and first aid supplies including respiratory equipment and consumables for its Fire Department Rescue Division through an IFB (due March 13, 2026, with an estimated contract value of $700,000); and the Minnesota Multistate Cooperative Purchasing Alliance is soliciting generic pharmaceuticals and OTC products through an RFP due March 26, 2026, with distribution through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson. The Tampa procurement carries a 5 percent bid discount for certified Small Local Business Enterprises, capped at $10,000. Geographic activity spans Florida, Texas, Minnesota, and Oregon through MMCAP. The mismatch between the code's stated scope and the actual work being procured suggests that labeling inconsistencies or categorical drift have reduced the relevance of this code for tracking lobendazole-specific opportunities.